{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:40Z","timestamp":1789042900626,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18828-8","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:53:18Z","timestamp":1759171998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrative genomic and immunoinformatic approach for characterizing HIV-1 pol, vpr, and Nef genes and designing a multi-epitope vaccine"],"prefix":"10.1038","volume":"15","author":[{"given":"Akmal","family":"Zubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranya Mohammed","family":"Elmagzoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"18828_CR1","unstructured":"UNAIDS, Global HIV statistics 2020. Ending the AIDS Epidemic. : pp. 1\u20133. (2020)."},{"key":"18828_CR2","doi-asserted-by":"publisher","first-page":"1259290","DOI":"10.3389\/fpsyt.2024.1259290","volume":"15","author":"J Ji","year":"2024","unstructured":"Ji, J. et al. People who living with HIV\/AIDS also have a high prevalence of anxiety disorders: a systematic review and meta-analysis. Front. Psychiatry. 15, 1259290 (2024).","journal-title":"Front. Psychiatry"},{"issue":"1S","key":"18828_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/QAI.0000000000003344","volume":"95","author":"C van Schalkwyk","year":"2024","unstructured":"van Schalkwyk, C. et al. Updated data and methods for the 2023 UNAIDS HIV estimates. JAIDS J. Acquir. Immune Defic. Syndr. 95 (1S), e1\u2013e4 (2024).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"18828_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clindermatol.2024.02.001","volume":"42","author":"S Payagala","year":"2024","unstructured":"Payagala, S. & Pozniak, A. The global burden of HIV. Clin. Dermatol. 42 (2), 119\u2013127 (2024).","journal-title":"Clin. Dermatol."},{"key":"18828_CR5","doi-asserted-by":"crossref","unstructured":"Zubair, A., Ali, M. & Akhtar, N. HIV-1 Nef Gene Characterization and Subtype Analysis in Pakistan: A Molecular Docking Approach with Mastoparan-L Peptide. International Journal of Peptide Research and Therapeutics, 31(3): p. 46. (2025).","DOI":"10.1007\/s10989-025-10702-5"},{"issue":"8","key":"18828_CR6","doi-asserted-by":"publisher","first-page":"e6687","DOI":"10.1371\/journal.pone.0006687","volume":"4","author":"ZL Brumme","year":"2009","unstructured":"Brumme, Z. L. et al. HLA-associated immune escape pathways in HIV-1 subtype B gag, pol and Nef proteins. PloS One. 4 (8), e6687 (2009).","journal-title":"PloS One"},{"issue":"3","key":"18828_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11262-025-02149-z","volume":"61","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Molecular characterization and drug resistance pattern in pol gene of HIV-1 sub-subtypes Circulating in lahore, Pakistan. Virus Genes. 61 (3), 324\u2013341 (2025).","journal-title":"Virus Genes"},{"issue":"2","key":"18828_CR8","first-page":"67","volume":"8","author":"KA Roebuck","year":"2018","unstructured":"Roebuck, K. A. & Saifuddin, M. Regulation of HIV-1 transcription. Gene Expr. 8 (2), 67 (2018).","journal-title":"Gene Expr."},{"issue":"2","key":"18828_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1172\/JCI80565","volume":"126","author":"DC Cary","year":"2016","unstructured":"Cary, D. C., Fujinaga, K. & Peterlin, B. M. Molecular mechanisms of HIV latency. J. Clin. Investig. 126 (2), 448\u2013454 (2016).","journal-title":"J. Clin. Investig."},{"issue":"5","key":"18828_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10142-024-01425-9","volume":"24","author":"A Zubair","year":"2024","unstructured":"Zubair, A. et al. Clinical trials and recent progress in HIV vaccine development. Funct. Integr. Genom. 24 (5), 143 (2024).","journal-title":"Funct. Integr. Genom."},{"issue":"7491","key":"18828_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature12966","volume":"507","author":"BE Correia","year":"2014","unstructured":"Correia, B. E. et al. Proof of principle for epitope-focused vaccine design. Nature 507 (7491), 201\u2013206 (2014).","journal-title":"Nature"},{"issue":"1\u20132","key":"18828_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijpharm.2012.03.019","volume":"429","author":"P Paix\u00e3o","year":"2012","unstructured":"Paix\u00e3o, P., Gouveia, L. F. & Morais, J. A. Prediction of the human oral bioavailability by using in vitro and in Silico drug related parameters in a physiologically based absorption model. Int. J. Pharm. 429 (1\u20132), 84\u201398 (2012).","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"18828_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.drudis.2011.10.023","volume":"17","author":"G Moroy","year":"2012","unstructured":"Moroy, G. et al. Toward in Silico structure-based ADMET prediction in drug discovery. Drug Discov Today. 17 (1\u20132), 44\u201355 (2012).","journal-title":"Drug Discov Today"},{"issue":"3","key":"18828_CR14","doi-asserted-by":"publisher","first-page":"e0317382","DOI":"10.1371\/journal.pone.0317382","volume":"20","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Targeting HIV-1 conserved regions: an immunoinformatic pathway to vaccine innovation for the Asia. PLOS ONE. 20 (3), e0317382 (2025).","journal-title":"PLOS ONE"},{"issue":"7","key":"18828_CR15","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1080\/07391102.2023.2297008","volume":"43","author":"AR Hameed","year":"2025","unstructured":"Hameed, A. R. et al. Exploring the hub genes and potential drugs involved in Fanconi anemia using microarray datasets and bioinformatics analysis. J. Biomol. Struct. Dyn. 43 (7), 3297\u20133310 (2025).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"18828_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/07391102.2023.2291541","volume":"43","author":"S Ahmad","year":"2025","unstructured":"Ahmad, S. et al. Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate. J. Biomol. Struct. Dyn. 43 (3), 1240\u20131248 (2025).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"24","key":"18828_CR17","doi-asserted-by":"publisher","first-page":"13876","DOI":"10.1080\/07391102.2023.2279276","volume":"42","author":"N Khan","year":"2024","unstructured":"Khan, N. et al. A novel therapeutic approach to prevent Helicobacter pylori induced gastric cancer using networking biology, molecular docking, and simulation approaches. J. Biomol. Struct. Dyn. 42 (24), 13876\u201313889 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"18828_CR18","unstructured":"Zubair, A. et al. mRNA vaccines against HIV: Hopes and challenges. HIV Medicine. n\/a(n\/a)."},{"key":"18828_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.compbiomed.2019.01.008","volume":"106","author":"SR Kazmi","year":"2019","unstructured":"Kazmi, S. R. et al. In Silico approaches and tools for the prediction of drug metabolism and fate: A review. Comput. Biol. Med. 106, 54\u201364 (2019).","journal-title":"Comput. Biol. Med."},{"key":"18828_CR20","doi-asserted-by":"crossref","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M. & Reche, P. A. Fundamentals and Methods for T- and B-Cell Epitope Prediction. J Immunol Res, 2017: p. 2680160. (2017).","DOI":"10.1155\/2017\/2680160"},{"key":"18828_CR21","doi-asserted-by":"crossref","unstructured":"Forsberg, R., M\u00f8nsted, S. & Hein, A. M. CLC Bio Integrated Platform for Handling and Analysis of Tag Sequencing Datap. 393\u2013405 (Tag-Based Next Generation Sequencing, 2011).","DOI":"10.1002\/9783527644582.ch25"},{"issue":"W1","key":"18828_CR22","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C. et al. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45 (W1), W24\u2013W29 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"7238","key":"18828_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nature07746","volume":"458","author":"Y Kawashima","year":"2009","unstructured":"Kawashima, Y. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458 (7238), 641\u2013645 (2009).","journal-title":"Nature"},{"issue":"8","key":"18828_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/bioinformatics\/btg108","volume":"19","author":"H Singh","year":"2003","unstructured":"Singh, H. & Raghava, G. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19 (8), 1009\u20131014 (2003).","journal-title":"Bioinformatics"},{"issue":"3\u20134","key":"18828_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.vaccine.2003.07.009","volume":"22","author":"LP Maccormac","year":"2004","unstructured":"Maccormac, L. P., Jacque, J. M. & Chain, B. The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector. Vaccine 22 (3\u20134), 528\u2013535. https:\/\/doi.org\/10.1016\/j.vaccine.2003.07.009 (2004).","journal-title":"Vaccine"},{"issue":"8","key":"18828_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3262","volume":"12","author":"SG Deeks","year":"2012","unstructured":"Deeks, S. G. et al. Towards an HIV cure: a global scientific strategy. Nat. Rev. Immunol. 12 (8), 607\u2013614 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"18828_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 1\u20137 (2007).","journal-title":"BMC Bioinform."},{"issue":"23","key":"18828_CR28","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan, C. N. et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics 26 (23), 2936\u20132943 (2010).","journal-title":"Bioinformatics"},{"issue":"8","key":"18828_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2020.1842976","volume":"114","author":"S Yadav","year":"2020","unstructured":"Yadav, S. et al. Design of a multi-epitope subunit vaccine for immune-protection against leishmania parasite. Pathog Glob Health. 114 (8), 471\u2013481 (2020).","journal-title":"Pathog Glob Health"},{"issue":"6","key":"18828_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon, C. & Deleage, G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11 (6), 681\u2013684 (1995).","journal-title":"Bioinformatics"},{"issue":"4","key":"18828_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16 (4), 404\u2013405 (2000).","journal-title":"Bioinformatics"},{"issue":"suppl_2","key":"18828_CR32","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gkh468","volume":"32","author":"DE Kim","year":"2004","unstructured":"Kim, D. E., Chivian, D. & Baker, D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 32 (suppl_2), W526\u2013W531 (2004).","journal-title":"Nucleic Acids Res."},{"key":"18828_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-3569-7_3","volume":"1414","author":"L Heo","year":"2016","unstructured":"Heo, L., Lee, H., Baek, M. & Seok, C. Binding site prediction of proteins with organic compounds or peptides using GALAXY web servers. Methods Mol. Biol. 1414, 33\u201345. https:\/\/doi.org\/10.1007\/978-1-4939-3569-7_3 (2016).","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"18828_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski, R. A. et al. PDBsum: structural summaries of PDB entries. Protein Sci. 27 (1), 129\u2013134 (2018).","journal-title":"Protein Sci."},{"key":"18828_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 1\u20138 (2008).","journal-title":"BMC Bioinform."},{"issue":"5","key":"18828_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nprot.2010.32","volume":"5","author":"SJ De Vries","year":"2010","unstructured":"De Vries, S. J., Van Dijk, M. & Bonvin, A. M. The HADDOCK web server for data-driven biomolecular Docking. Nat. Protoc. 5 (5), 883\u2013897 (2010).","journal-title":"Nat. Protoc."},{"issue":"14","key":"18828_CR37","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","volume":"27","author":"N Rapin","year":"2011","unstructured":"Rapin, N., Lund, O. & Castiglione, F. Immune system simulation online. Bioinformatics 27 (14), 2013\u20132014 (2011).","journal-title":"Bioinformatics"},{"issue":"W1","key":"18828_CR38","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R. et al. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 42 (W1), W271\u2013W276 (2014).","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"18828_CR39","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote, A. et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33 (suppl_2), W526\u2013W531 (2005).","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"18828_CR40","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.vaccine.2018.03.042","volume":"36","author":"RK Pandey","year":"2018","unstructured":"Pandey, R. K. et al. Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection. Vaccine 36 (17), 2262\u20132272 (2018).","journal-title":"Vaccine"},{"issue":"10","key":"18828_CR41","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S. et al. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17 (10), 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"18828_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 514 (2008).","journal-title":"BMC Bioinform."},{"issue":"1","key":"18828_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41385-019-0221-x","volume":"13","author":"H Rabezanahary","year":"2020","unstructured":"Rabezanahary, H. et al. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques. Mucosal Immunol. 13 (1), 149\u2013160 (2020).","journal-title":"Mucosal Immunol."},{"issue":"11","key":"18828_CR44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes, J. D. et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med. 23 (11), 1271\u20131276 (2017).","journal-title":"Nat. Med."},{"issue":"5","key":"18828_CR45","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","volume":"48","author":"PD Kwong","year":"2018","unstructured":"Kwong, P. D. & Mascola, J. R. HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure. Immunity 48 (5), 855\u2013871. https:\/\/doi.org\/10.1016\/j.immuni.2018.04.029 (2018).","journal-title":"Immunity"},{"key":"18828_CR46","doi-asserted-by":"publisher","unstructured":"Karpenko, L. I. et al. Artificial epitope-based immunogens in HIV-vaccine design, in Advances in HIV and AIDS Control. IntechOpen London, UK. p. (2018). https:\/\/doi.org\/10.5772\/intechopen.77031","DOI":"10.5772\/intechopen.77031"},{"issue":"2","key":"18828_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","volume":"411","author":"IJ Amanna","year":"2011","unstructured":"Amanna, I. J. & Slifka, M. K. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411 (2), 206\u2013215. https:\/\/doi.org\/10.1016\/j.virol.2010.12.016 (2011).","journal-title":"Virology"},{"issue":"12","key":"18828_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/prot.25609","volume":"86","author":"N Khairkhah","year":"2018","unstructured":"Khairkhah, N. et al. Prediction of cross-clade HIV\u20101 T\u2010cell epitopes using immunoinformatics analysis. Proteins Struct. Funct. Bioinform. 86 (12), 1284\u20131293. https:\/\/doi.org\/10.1002\/prot.25609 (2018).","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"3","key":"18828_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","volume":"11","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. In Silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum. Vaccines Immunotherapeutics. 11 (3), 795\u2013805. https:\/\/doi.org\/10.1080\/21645515.2015.1012017 (2015).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"issue":"1","key":"18828_CR50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1567201818666210224101144","volume":"19","author":"F Namazi","year":"2022","unstructured":"Namazi, F., Davoodi, S. & Bolhassani, A. Comparison of the efficacy of HIV-1 Nef-Tat-Gp160-p24 polyepitope vaccine candidate with Nef protein in different immunization strategies. Curr. Drug Deliv. 19 (1), 142\u2013156. https:\/\/doi.org\/10.2174\/1567201818666210224101144 (2022).","journal-title":"Curr. Drug Deliv."},{"key":"18828_CR51","doi-asserted-by":"publisher","unstructured":"Chakraborty, S., Rahman, T. & Chakravorty, R. Characterization of the protective HIV-1 CTL epitopes and the corresponding HLA class I alleles: A step towards designing CTL based HIV-1 vaccine. Advances in virology, 2014. 2014(1): p. 321974 .https:\/\/doi.org\/10.1155\/2014\/321974","DOI":"10.1155\/2014\/321974"},{"key":"18828_CR52","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10529-019-02734-x","volume":"43","author":"S Davoodi","year":"2021","unstructured":"Davoodi, S., Bolhassani, A. & Namazi, F. Vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Biotechnol. Lett. 43, 547\u2013559. https:\/\/doi.org\/10.1007\/s10529-019-02734-x (2021).","journal-title":"Biotechnol. Lett."},{"issue":"8","key":"18828_CR53","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s10529-021-03143-9","volume":"43","author":"E Akbari","year":"2021","unstructured":"Akbari, E. et al. In Silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Biotechnol. Lett. 43 (8), 1513\u20131550. https:\/\/doi.org\/10.1007\/s10529-021-03143-9 (2021).","journal-title":"Biotechnol. Lett."},{"issue":"3","key":"18828_CR54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acsabm.1c01238","volume":"5","author":"IW Hamley","year":"2022","unstructured":"Hamley, I. W. Peptides for vaccine development. ACS Appl. Bio Mater. 5 (3), 905\u2013944 (2022).","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"18828_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2004.06.004","volume":"326","author":"E Shinya","year":"2004","unstructured":"Shinya, E. et al. Endogenously expressed HIV-1 Nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells. Virology 326 (1), 79\u201389. https:\/\/doi.org\/10.1016\/j.virol.2004.06.004 (2004).","journal-title":"Virology"},{"issue":"3","key":"18828_CR56","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1128\/JVI.73.3.1964-1973.1999","volume":"73","author":"A Mangasarian","year":"1999","unstructured":"Mangasarian, A. et al. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 (3), 1964\u20131973. https:\/\/doi.org\/10.1128\/JVI.73.3.1964-1973.1999 (1999).","journal-title":"J. Virol."},{"issue":"2","key":"18828_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chom.2007.03.004","volume":"1","author":"CH Hung","year":"2007","unstructured":"Hung, C. H. et al. HIV-1 Nef assembles a Src family kinase-ZAP-70\/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell. Host Microbe. 1 (2), 121\u2013133. https:\/\/doi.org\/10.1016\/j.chom.2007.03.004 (2007).","journal-title":"Cell. Host Microbe"},{"issue":"1","key":"18828_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1182\/blood-2012-02-409870","volume":"120","author":"DY Chen","year":"2012","unstructured":"Chen, D. Y. et al. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes. Blood. J. Am. Soc. Hematol. 120 (1), 100\u2013111. https:\/\/doi.org\/10.1182\/blood-2012-02-409870 (2012).","journal-title":"J. Am. Soc. Hematol."},{"issue":"1","key":"18828_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12859-022-04816-6","volume":"23","author":"S Saha","year":"2022","unstructured":"Saha, S. et al. In-silico design of an immunoinformatics based multi-epitope vaccine against leishmania donovani. BMC Bioinform. 23 (1), 319. https:\/\/doi.org\/10.1186\/s12859-022-04816-6 (2022).","journal-title":"BMC Bioinform."},{"key":"18828_CR60","unstructured":"Piantadosi, S. Clinical Trials: a Methodologic Perspective (Wiley, 2024)."},{"issue":"5","key":"18828_CR61","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.joim.2024.06.005","volume":"22","author":"AL Tournier","year":"2024","unstructured":"Tournier, A. L. et al. Scientific guidelines for preclinical research on potentised preparations manufactured according to current pharmacopoeias-the PrePoP guidelines. J. Integr. Med. 22 (5), 533\u2013544 (2024).","journal-title":"J. Integr. Med."},{"key":"18828_CR62","doi-asserted-by":"publisher","unstructured":"Marshall, J. L. Testing vaccines: essential steps in clinical trial design, in Vaccinology and Methods in Vaccine Research. Elsevier. 295\u2013310. https:\/\/doi.org\/10.1016\/B978-0-323-91146-7.00002-0. (2022).","DOI":"10.1016\/B978-0-323-91146-7.00002-0"},{"key":"18828_CR63","doi-asserted-by":"crossref","unstructured":"Ellis, R. W. Combination Vaccines: Development, Clinical Research, and Approval (Springer Science & Business Media, 1999).","DOI":"10.1007\/978-1-59259-265-4"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18828-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18828-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18828-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:53:20Z","timestamp":1759172000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18828-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18828"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18828-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethical Committee of Quaid-i-Azam University, Islamabad, Pakistan, under protocol numbers BEC-FBS-QAU2023-520 (dated September 12, 2023) and BEC-FBS-QAU2020-232 (dated February 6, 2020). There are no human or animal participants in this study. Only serum samples from people with HIV were collected. The patients (or, in the case of babies, their guardians) gave their informed written permission. Furthermore, patients\u2019 personal information is not needed for this study. Every technique was carried out in compliance with the applicable rules and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study does not involve any human or animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human research"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"33690"}}